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of hnRNP-K to specific genomic loci? 
Is there functional significance to the 
remarkable proximity (?15 kb) of lin-
cRNA-p21 to the p21 gene? If these loci 
are regulated interdependently, they may 
act as a key molecular switch between 
life and death. Finally, given the impor-
tance of lincRNA-p21 to p53-dependent 
cell death, is lincRNA-p21 mutated in 
cancer? Answers to each of these ques-
tions will certainly enrich our under-
standing of the functional relationship 
between p53 and this powerful class of 
regulatory molecules, lincRNAs.
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Stem cells have the immense responsi-
bility of maintaining tissue and organism 
homeostasis over the lifetime of an indi-
vidual. As such, stem cells are speculated 
to have evolutionary characteristics that 
offer protection against acute insults, 
allowing them to survive and to repopu-
late their tissues in the short term. How-
ever, they must also act as self-renew-
ing guardians of the genome to ensure 
maximal integrity of the genomic code 
for future stem cells and their mature tis-
sue progeny. The hematopoietic (blood) 
system is perhaps the best studied tis-
sue in terms of its hierarchical develop-
ment from a small number of long-term 
stem cells that are relatively quiescent, 
to progenitors that proliferate and dif-
ferentiate, and then to mature blood cell 
lineages that are produced by the billion 
each day. Hematopoietic stem cells are 
thought to be resistant to injury including 
DNA damage, which may be related to 
their specific gene expression programs, 
epigenetic factors, or exogenous protec-
tion by the stem cell “niche.” Two new 
reports in Cell Stem Cell from the labora-
tories of Emmanuelle Passegué (Mohrin 
et al., 2010) and John Dick (Milyavsky et 
al., 2010) further our understanding of 
how hematopoietic stem cells respond 
to radiation-induced DNA damage.
So how do quiescent stem cells han-
dle genotoxic insults? Mohrin et al. (2010) 
found that murine hematopoietic stem 
and progenitor cells (HSPCs)—defined as 
bone marrow cells expressing the mark-
ers: lineage−/c-Kit+/Sca-1+/Flk2−—were 
more resistant to apoptosis induced 
by a specific dose of ionizing radiation 
than were more differentiated progenitor 
cells (Figure 1). The unique DNA damage 
response of mouse HSPCs involves the 
tumor suppressor protein p53 and is lost 
when stem cells are forced out of qui-
escence and into the cell cycle by treat-
ment with chemotherapy or cytokines. 
Not only are quiescent HSPCs poised 
to resist apoptosis as evidenced by their 
antiapoptotic gene expression program, 
but they are also able to repair their DNA 
by nonhomologous end joining (NHEJ). 
Repair of DNA damage through homolo-
gous recombination (which has a lower 
error rate than NHEJ) requires that cells 
enter the cell cycle; thus, quiescent stem 
cells must rely on NHEJ as an alterna-
tive. The reliance of quiescent adult tis-
sue stem cells on NHEJ for the repair of 
DNA damage may in fact be a general 
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Stem cells repopulate tissues after injury while also renewing themselves, but this makes them 
vulnerable to genotoxic damage. Mohrin et al. (2010) and Milyavsky et al. (2010) now show that 
mouse and human hematopoietic stem cells make opposing decisions about whether to die or to 
persist in response to DNA damage.
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phenomenon in mice, given 
the similar conclusions of a 
recent study using hair follicle 
stem cells as a model system 
(Sotiropoulou et al., 2010).
Unfortunately, Mohrin et al. 
(2010) also uncover a down-
side to short-term radioresis-
tance and rapid DNA repair 
through the error-prone NHEJ 
pathway. Spectral karyotyping 
revealed gross chromosomal 
aberrations in irradiated mouse 
HSPCs, and some of the same 
abnormal cytogenetic find-
ings persisted in the progeny 
of irradiated HSPCs trans-
planted into mouse recipients. 
Furthermore, despite their 
resistance to apoptosis imme-
diately after injury, irradiated 
HSPCs were unable to con-
tribute to long-term sustained 
hematopoiesis when seri-
ally transplanted into mouse 
recipients. Such events would 
be of obvious risk to a long-
lived organism as serial expo-
sure of stem cells to genotoxic 
agents could readily result in 
leukemia or aplasia.
Does the human hemato-
poietic system accept the 
same tradeoff between stem 
cell survival in the short term 
versus accumulation of del-
eterious mutations in the long 
term? In a companion study, 
Milyavsky et al. (2010) addressed this 
question in human umbilical cord blood 
cells. They observed an enhanced sen-
sitivity to apoptosis induced by low-dose 
ionizing radiation in these cells compared 
to more differentiated cells. In contrast 
to the findings of Mohrin et al. in the 
mouse, these authors noted that human 
hematopoietic stem and early multipotent 
progenitor cells were poised for apopto-
sis in response to DNA damage. Survival 
and the clonogenic and reconstitutive 
capacity of the irradiated human HSPCs 
were rescued by blocking p53 expression 
or by overexpression of the antiapoptotic 
factor Bcl-2. However, irradiated human 
HSPCs lacking p53 were unable to sus-
tain hematopoiesis and showed evidence 
of persistent DNA double-strand breaks 
when serially transplanted into recipi-
ent mice. Therefore, a short-term gain 
in survival could be achieved by human 
hematopoietic stem cells as found in the 
mouse, but the default setting for irradi-
ated human HSPCs is an increase in p53 
expression resulting in apoptosis.
The differences between these two 
studies may have a technical basis: mark-
ers for stem and progenitor populations 
are more refined in the mouse than in the 
human so somewhat different stem and 
progenitor cell populations may have 
been analyzed. In addition, slightly differ-
ent doses of radiation were used. In the 
in vivo experiments of Milyavsky et al., 
human HSPCs from umbilical cord blood 
were transplanted into the mouse bone 
marrow niche, which may have provided 
less efficient survival signals for human 
cells than for mouse cells. Also, human 
umbilical cord blood HSPCs 
have a different biology than 
the bone marrow HSPCs of 
mouse. However, it is tempt-
ing to see the different find-
ings in the light of evolution, 
that is, as a reflection of the 
different challenges faced by 
mammals with different life 
spans and ages of reproduc-
tive maturity.
Recent elegant studies from 
Bondar and Medzhitov (2010) 
and Marusyk et al. (2010) 
demonstrate that competitive 
selection takes place within 
tissue stem cell populations. 
These authors found that irra-
diated p53-deficient HSPCs 
in the mouse have an initial 
survival advantage but that 
long-term fitness is balanced 
by complex interactions with 
neighboring HSPCs and the 
relative levels of p53 and DNA 
damage in stem cells and their 
neighbors. The studies from the 
Passegué and Dick labs indi-
cate that hematopoietic cells 
within a tissue have adopted 
different means of handling 
DNA damage depending on 
their differentiation stage. That 
mouse and human stem cells 
may have acquired or under-
gone selection for distinct 
responses to ionizing radiation 
is a reasonable notion. How-
ever, it remains to be seen which specific 
molecular mechanisms that differ between 
stem cells and progenitors, or between 
stem cells of different species, lead to 
these distinctive traits. We now have a set 
of reagents with which to discover and 
understand how such important yet differ-
ent tissue stem cell traits have evolved.
There are other practical implications 
of the Passegué and Dick reports. Sec-
ondary myelodysplasia and leukemia are 
believed to arise from DNA damage to 
HSPCs from the radiation or chemother-
apy given to treat a primary malignancy. 
Mohrin et al. show intriguing evidence that 
NHEJ activity and chromosomal aberra-
tions decrease when HSPCs are induced 
to enter the cell cycle prior to irradiation. 
Interestingly, a parallel evolving hypoth-
esis in the study of cancer stem cells sug-
figure 1. Hematopoietic cell Responses to DnA Damage
(Top) Quiescent murine hematopoietic stem and progenitor cells (HSPCs) 
are poised to survive DNA damage induced by low-level ionizing radiation 
through a DNA repair process called nonhomologous end joining (NHEJ), 
which tends to be error prone (Mohrin et al., 2010). In contrast, mouse HSPCs 
and committed progenitors (CP) progressing through the cell cycle are more 
likely to undergo apoptosis or repair their DNA using higher-fidelity homolo-
gous recombination. Although the short-term consequence of HSPC survival 
is maintenance of tissue integrity in the face of injury, long-term consequenc-
es include genomic rearrangements that persist and HSPCs with a diminished 
functional capacity. 
(Bottom) In contrast, compared to more committed progenitors, the default 
program for damaged human HSPCs is to undergo apoptosis. However, a de-
crease in p53 rescues human HSPCs from apoptosis immediately after low-
level irradiation (Milyavsky et al., 2010). Despite interspecies differences in 
the short-term response to radiation, the long-term functional consequences 
of avoiding apoptosis for both mouse and human HSPCs include persistent 
DNA damage and decreased self-renewal capacity. The delicate balance be-
tween tissue survival and the DNA damage response therefore could predis-
pose surviving HSPCs to future malignant transformation.
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gests that activating leukemia stem cells 
from quiescence prior to chemotherapy 
may result in more efficient elimination of 
these cancer-repopulating cells (Saito et 
al., 2010). An unexpected benefit of such 
a prestimulation strategy may be that nor-
mal hematopoietic stem cells activated 
from quiescence would simultaneously 
be protected from accumulating long-
term DNA damage. However, as shown 
by Milyavsky and colleagues, stem cell 
escape from acute damage, particularly if 
it involves a decrease in p53 activity, may 
lead to long-term deleterious effects on 
stem cell fitness and repopulating ability. 
The interplay between the response to 
acute injury and long-term fitness needs 
to be more fully understood and will 
require both laboratory models and the 
thoughtful correlative study of stem cells 
from patients receiving genotoxic chemo-
therapy. Understanding these events may 
point the way to methods for preserving 
short-term tissue reconstitution while 
maintaining long-term cell and genomic 
integrity.
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Mitochondria, the power plants of the 
eukaryotic cell, are bound by two mem-
branes and contain 1000–1500 different 
proteins and tens of RNAs. Most of the 
genes that encode mitochondrial pro-
teins are found in the nuclear genome 
and thus are translated in the cytosol 
and then imported into mitochondria. 
The pathways and machineries required 
for protein import into mitochondria 
have been extensively studied and are 
highly conserved among fungi, plants, 
and mammals (Endo and Yamano 2009; 
Chacinska et al., 2009). The mitochon-
drial matrix also contains several kinds of 
noncoding RNAs that are also imported 
from the cytosol. However, in contrast to 
protein translocation, the mechanisms 
that mediate import of RNAs into mito-
chondria remain enigmatic (Salinas et al., 
2008; Lithgow and Schneider, 2010). In 
this issue of Cell, Wang et al. (2010) shed 
light on this question, revealing that poly-
nucleotide phosphorylase (PNPase) is a 
much sought after component of the RNA 
import apparatus in mammalian cells.
PNPases comprise an evolutionally 
conserved enzyme family (found in bac-
teria, plants, flies, and mammals but not 
in yeast) that has 3′→5′ exoribonuclease 
and RNA-polymerase activities (Chen et 
al., 2007). Although bacterial PNPases 
are cytosolic, eukaryotic PNPases are 
mainly localized in mitochondria or chlo-
roplasts. Prior work has established 
how PNPases get to the intermembrane 
space (IMS). After crossing the mito-
chondrial outer membrane via the trans-
locase of outer mitochondrial membrane 
40 (TOM40) complex, the PNPase pre-
cursor engages with the translocase of 
the inner membrane 23 (TIM23) complex 
(Figure 1) (Chen et al., 2006; Rainey et al., 
2006). After the PNPase presequence is 
removed by matrix processing pepti-
dase (MPP), an AAA protease Yme1 in 
the inner membrane pulls PNPase into 
the IMS, where PNPase assembles into 
a trimeric complex (Figure 1).
Wang et al. now assess the function of 
mammalian PNPase by tissue-specific 
disruption of the PNPase gene in mouse 
hepatocytes. They find that mitochondria 
from hepatocytes deficient in PNPase 
display defects in oxidative phosphory-
lation (OXPHOS), the major ATP-gener-
ating metabolic pathway of respiration. 
This defect is shown to arise from the 
failure in the processing of polycistronic 
mitochondrial mRNAs encoding the 
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Although mitochondrial biogenesis requires the import of specific RNAs, the pathways and cellular 
machineries involved are only poorly understood. Wang et al. (2010) now find that polynucleotide 
phosphorylase in the intermembrane space of mammalian mitochondria facilitates import of 
several RNAs into the mitochondrial matrix.
